191 related articles for article (PubMed ID: 25371972)
1. Gallium maltolate inhibits human cutaneous T-cell lymphoma tumor development in mice.
Wu X; Wang TW; Lessmann GM; Saleh J; Liu X; Chitambar CR; Hwang ST
J Invest Dermatol; 2015 Mar; 135(3):877-884. PubMed ID: 25371972
[TBL] [Abstract][Full Text] [Related]
2. Development of gallium compounds for treatment of lymphoma: gallium maltolate, a novel hydroxypyrone gallium compound, induces apoptosis and circumvents lymphoma cell resistance to gallium nitrate.
Chitambar CR; Purpi DP; Woodliff J; Yang M; Wereley JP
J Pharmacol Exp Ther; 2007 Sep; 322(3):1228-36. PubMed ID: 17600139
[TBL] [Abstract][Full Text] [Related]
3. Gallium Maltolate Disrupts Tumor Iron Metabolism and Retards the Growth of Glioblastoma by Inhibiting Mitochondrial Function and Ribonucleotide Reductase.
Chitambar CR; Al-Gizawiy MM; Alhajala HS; Pechman KR; Wereley JP; Wujek R; Clark PA; Kuo JS; Antholine WE; Schmainda KM
Mol Cancer Ther; 2018 Jun; 17(6):1240-1250. PubMed ID: 29592883
[TBL] [Abstract][Full Text] [Related]
4. Gallium maltolate has
Bernstein LR; Zhang L
Antivir Chem Chemother; 2020; 28():2040206620983780. PubMed ID: 33353394
[TBL] [Abstract][Full Text] [Related]
5. Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma.
Jain S; Stroopinsky D; Yin L; Rosenblatt J; Alam M; Bhargava P; Clark RA; Kupper TS; Palmer K; Coll MD; Rajabi H; Pyzer A; Bar-Natan M; Luptakova K; Arnason J; Joyce R; Kufe D; Avigan D
Blood; 2015 Jul; 126(3):354-62. PubMed ID: 26048911
[TBL] [Abstract][Full Text] [Related]
6. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
Wang Y; Gu X; Li W; Zhang Q; Zhang C
J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation.
Geskin LJ; Viragova S; Stolz DB; Fuschiotti P
Blood; 2015 Apr; 125(18):2798-805. PubMed ID: 25628470
[TBL] [Abstract][Full Text] [Related]
8. Involvement of p53 Acetylation in Growth Suppression of Cutaneous T-Cell Lymphomas Induced by HDAC Inhibition.
Yu X; Li H; Zhu M; Hu P; Liu X; Qing Y; Wang X; Wang H; Wang Z; Xu J; Tan R; Guo Q; Hui H
J Invest Dermatol; 2020 Oct; 140(10):2009-2022.e4. PubMed ID: 32119867
[TBL] [Abstract][Full Text] [Related]
9. Targeting apoptosis defects in cutaneous T-cell lymphoma.
Contassot E; French LE
J Invest Dermatol; 2009 May; 129(5):1059-61. PubMed ID: 19369931
[TBL] [Abstract][Full Text] [Related]
10. Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma.
Chua MS; Bernstein LR; Li R; So SK
Anticancer Res; 2006; 26(3A):1739-43. PubMed ID: 16827101
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.
Abe F; Kitadate A; Ikeda S; Yamashita J; Nakanishi H; Takahashi N; Asaka C; Teshima K; Miyagaki T; Sugaya M; Tagawa H
Oncotarget; 2017 Jan; 8(5):7572-7585. PubMed ID: 27935859
[TBL] [Abstract][Full Text] [Related]
13. STAT3 knockdown by siRNA induces apoptosis in human cutaneous T-cell lymphoma line Hut78 via downregulation of Bcl-xL.
Verma NK; Davies AM; Long A; Kelleher D; Volkov Y
Cell Mol Biol Lett; 2010 Jun; 15(2):342-55. PubMed ID: 20213502
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the antimicrobial activities of gallium nitrate and gallium maltolate against Mycobacterium avium subsp. paratuberculosis in vitro.
Fecteau ME; Aceto HW; Bernstein LR; Sweeney RW
Vet J; 2014 Oct; 202(1):195-7. PubMed ID: 25155307
[TBL] [Abstract][Full Text] [Related]
15. Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice.
DeLeon K; Balldin F; Watters C; Hamood A; Griswold J; Sreedharan S; Rumbaugh KP
Antimicrob Agents Chemother; 2009 Apr; 53(4):1331-7. PubMed ID: 19188381
[TBL] [Abstract][Full Text] [Related]
16. IL-10 is overexpressed in human cutaneous T-cell lymphoma and is required for maximal tumor growth in a mouse model.
Wu X; Hsu DK; Wang KH; Huang Y; Mendoza L; Zhou Y; Hwang ST
Leuk Lymphoma; 2019 May; 60(5):1244-1252. PubMed ID: 30277131
[TBL] [Abstract][Full Text] [Related]
17. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells.
Zhang C; Li B; Gaikwad AS; Haridas V; Xu Z; Gutterman JU; Duvic M
J Invest Dermatol; 2008 Nov; 128(11):2728-2735. PubMed ID: 18496567
[TBL] [Abstract][Full Text] [Related]
18. Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma.
Nieto-Rementería N; Pérez-Yarza G; Boyano MD; Apraiz A; Izu R; Díaz-Pérez JL; Asumendi A
Br J Dermatol; 2009 Mar; 160(3):519-26. PubMed ID: 19067706
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma detection by gallium scan and subsequent treatment by gallium maltolate: rationale and case study.
Bernstein LR; van der Hoeven JJ; Boer RO
Anticancer Agents Med Chem; 2011 Jul; 11(6):585-90. PubMed ID: 21554205
[TBL] [Abstract][Full Text] [Related]
20. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.
Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]